Using awe to encourage adults to take preventive steps like vaccination, mask-wearing, and social distancing
Official title: Fostering Prosocial Behaviours Against Infectious Diseases Through Awe: A Randomized Controlled Trial
Run by The University of Hong Kong · NCT07406529 · Data updated 2026-11-12
This project will test if feeling awe makes adults in Hong Kong, Singapore, and major Mainland Chinese cities more likely to get vaccinated, wear masks, and keep social distance.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 456 (estimated) |
| Sponsor | The University of Hong Kong Academic / other |
| Locations | 1 site (Hong Kong) |
| Status | Recruiting |
| Started | October 27, 2025 |
| Main results expected | March 31, 2026 |
| Study ends | October 31, 2026 |
| Registry record updated | February 27, 2026 |
| Trial ID | NCT07406529 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older who have lived in Hong Kong, Singapore, or one of the ten listed Mainland China cities in the past year, can read Chinese or English, have internet access, and agreed to be recontacted from the baseline survey are ideal candidates.
✕Probably not a fit
People without reliable internet access, those who cannot read Chinese or English, those living outside the listed locations, or individuals with cognitive or linguistic difficulties preventing online participation are unlikely to benefit from this online intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This nested randomized controlled trial recruits adults who participated in a prior online longitudinal survey and agreed to be recontacted, randomizing them 1:1 to an awe-induction or a neutral-imagination control delivered online. The intervention is delivered approximately four months after the baseline assessment (Feb–Mar 2026) and outcomes are measured by intentions to engage in prosocial preventive behaviours such as vaccination, mask-wearing, and social distancing. The trial is implemented across Hong Kong, Singapore, and ten major Mainland China cities using online surveys and brief experimental tasks. Analyses will compare post-intervention intentions between groups and examine whether effects differ by site.
Why it matters
Potential benefit: If successful, the approach could increase people's willingness to take preventive actions like vaccination and mask-wearing, which may reduce infectious disease spread.
How similar studies have gone: Prior psychological research shows awe can increase prosocial intentions, but applying awe specifically to increase infectious-disease preventive behaviours in randomized trials is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults (age ≥18 years) who live in * Hong Kong, Singapore, and ten major cities in Mainland China (Beijing, Shanghai, Guangzhou, Shenzhen, Hangzhou, Chongqing, Chengdu, Wuhan, Xi'an, Nanjing) over the past one year * Able to read and understand written Chinese or English * Have access to the internet through computers, mobile phones, or tablets Exclusion Criteria: * Individuals with cognitive or linguistic difficulties that would prevent them from completing an online survey will be excluded.
Where it's running
-
University of Hong Kong School of Public Health
Hong Kong, Hong Kong Recruiting
Study contacts
- Study coordinator: Qiuyan Liao
- Email: qyliao11@hku.hk
- Phone: 39179289
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Dietitian-led nutrition care in hospital wards
This trial tests whether having clinical dietitians lead nutritional care for adults in medical wards improves meals, well‑being, and reduces hospital stay and costs.
-
Digital prescription tool to help GPs follow antibiotic guidelines in Belgian primary care
This project will test whether a digital Prescription Support System helps general practitioners in Belgium prescribe antibiotics more in line with national guidelines.
-
Safety and dosing of BWC0977 in healthy adults
This study will test whether single and multiple IV doses of BWC0977 are safe and well tolerated in healthy adults.
-
Long-term monitoring of adults with type I interferon autoantibodies or genetic interferon defects
We will follow adults who have autoantibodies to type I interferons or genetic defects that impair interferon responses to see if they develop more infections or autoimmune problems and how antibody levels change over time.
-
Understanding HIV infection through blood cell studies
This study is testing how HIV affects the immune system by looking at blood samples from people living with the virus to better understand the disease.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.